Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid for blood loss reduction in DHS surgery for intertrochanteric femur fracture in elderly patients
IRCT20250310065024N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intertrochanteric fracture comparing Oral tranexamic acid with Placebo (2 arms). Primary endpoints: Age, Gender and 8 more. Started Apr 2025; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on IRCT20250310065024N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250310065024N1.